Full text is available at the source.
Effects of glucagon-like peptide-1 receptor agonists on upper endoscopy in diabetic and nondiabetic patients
Effects of glucagon-like peptide-1 receptor agonists on upper digestive tract examinations in people with and without diabetes
AI simplified
Abstract
GLP-1 receptor agonist use is associated with a 4-fold increase in the retention of gastric contents during EGD procedures.
- Use of GLP-1 receptor agonists is linked to 4-fold higher rates of aborted EGD.
- Patients on GLP-1 receptor agonists are twice as likely to require repeat EGD.
- Delayed gastric emptying may impact the adequacy of EGD, regardless of diabetes status.
- Dose adjustments of GLP-1 receptor agonists may be necessary to enhance the safety of EGD procedures.
AI simplified